EMAIL THIS PAGE TO A FRIEND

PloS one

Expression and Regulation of Cav3.2 T-Type Calcium Channels during Inflammatory Hyperalgesia in Mouse Dorsal Root Ganglion Neurons.


PMID 25974104

Abstract

The Cav3.2 isoform of the T-type calcium channel is expressed in primary sensory neurons of the dorsal root ganglion (DRG), and these channels contribute to nociceptive and neuropathic pain in rats. However, there are conflicting reports on the roles of these channels in pain processing in rats and mice. In addition, the function of T-type channels in persistent inflammatory hyperalgesia is poorly understood. We performed behavioral and comprehensive histochemical analyses to characterize Cav3.2-expressing DRG neurons and examined the regulation of T-type channels in DRGs from C57BL/6 mice with carrageenan-induced inflammatory hyperalgesia. We show that approximately 20% of mouse DRG neurons express Cav3.2 mRNA and protein. The size of the majority of Cav3.2-positive DRG neurons (69 ± 8%) ranged from 300 to 700 μm2 in cross-sectional area and 20 to 30 μm in estimated diameter. These channels co-localized with either neurofilament-H (NF-H) or peripherin. The peripherin-positive cells also overlapped with neurons that were positive for isolectin B4 (IB4) and calcitonin gene-related peptide (CGRP) but were distinct from transient receptor potential vanilloid 1 (TRPV1)-positive neurons during normal mouse states. In mice with carrageenan-induced inflammatory hyperalgesia, Cav3.2 channels, but not Cav3.1 or Cav3.3 channels, were upregulated in ipsilateral DRG neurons during the sub-acute phase. The increased Cav3.2 expression partially resulted from an increased number of Cav3.2-immunoreactive neurons; this increase in number was particularly significant for TRPV1-positive neurons. Finally, preceding and periodic intraplantar treatment with the T-type calcium channel blockers mibefradil and NNC 55-0396 markedly reduced and reversed mechanical hyperalgesia during the acute and sub-acute phases, respectively, in mice. These data suggest that Cav3.2 T-type channels participate in the development of inflammatory hyperalgesia, and this channel might play an even greater role in the sub-acute phase of inflammatory pain due to increased co-localization with TRPV1 receptors compared with that in the normal state.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

SAB4503503
Anti-CACNA1H antibody produced in rabbit, affinity isolated antibody
HPA039125 Anti-CACNA1H antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
C1868
Anti-Calcium Channel CaV3.2 (α1H) antibody produced in rabbit, affinity isolated antibody, lyophilized powder
SAB3700280 Anti-goat IgG (H+L) antibody produced in donkey, affinity isolated antibody, buffered aqueous solution
SAB3700328 Anti-Goat IgG (H+L), F(ab) fragment- antibody produced in donkey, affinity isolated antibody, buffered aqueous solution
SAB4502419
Anti-Peripherin, C-Terminal antibody produced in rabbit, affinity isolated antibody
SAB2105006
Anti-PRPH antibody produced in rabbit, affinity isolated antibody
SAB1411104
Anti-PRPH antibody produced in rabbit, purified immunoglobulin, buffered aqueous solution
SAB2105005
Anti-PRPH, (N-terminal) antibody produced in rabbit, affinity isolated antibody
SAB3700932 Anti-Rabbit IgG (H+L) antibody produced in donkey, affinity isolated antibody, buffered aqueous solution
SAB3700976 Anti-Rabbit IgG (H+L), F(ab) fragment antibody produced in donkey, affinity isolated antibody, buffered aqueous solution
M2028
Capsaicin, ≥95%, from Capsicum sp.
C18H27NO3
360376
Capsaicin, natural
C18H27NO3
21750
Capsaicin, from Capsicum sp., ≥50% (HPLC)
C18H27NO3
WH0000796M1
Monoclonal Anti-CALCA antibody produced in mouse, clone 4B10, purified immunoglobulin, buffered aqueous solution
P5117
Monoclonal Anti-Peripherin antibody produced in mouse, clone 8G2, purified immunoglobulin, buffered aqueous solution
SAB1401314
Monoclonal Anti-PRPH antibody produced in mouse, clone 3B3, purified immunoglobulin, buffered aqueous solution
84010
NBT Vials, for in vitro diagnostic use
C40H30Cl2N10O6
N6876
Nitrotetrazolium Blue chloride, ~98% (TLC)
C40H30Cl2N10O6
N6639
Nitrotetrazolium Blue chloride, powder, electrophoresis grade
C40H30Cl2N10O6
74032
Nitrotetrazolium Blue chloride, ≥98.0% (calc. based on dry substance, T)
C40H30Cl2N10O6